NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.92% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.88% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.98% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.60% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.48% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.21% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 3.51% |
DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.23% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 3.07% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.83% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.67% |
ABT | Abbott Laboratories | Healthcare | Medical Devices | 2.31% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.27% |
SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 2.27% |
GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 2.26% |
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.21% |
LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.18% |
HCA | HCA Holdings Inc | Healthcare | Medical Care Facilities | 1.99% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 1.97% |